Venture Capital and Growth Companies

Supporting VCs and growth companies through their journeys from start-up, through growth phases and to maturity and exit.

We advise growth equity investors from early stage, late stage and growth venture funds through to large, international venture capital firms and institutional investors. We also advise the full spectrum of growth companies from start-ups to some of the largest and fastest growing companies in Europe. Our standards of technical excellence, commercial pragmatism and client-focused service apply to all our clients in this space – however big or small.

We have one of the strongest corporate practices in the world and are one of the top law firms for acquisitions, mergers and investments, leading on many of the major European fundraisings in recent times.

What makes us stand out though is our wider expertise. Our multi-disciplinary team has recognised market-leading expertise in Financial Regulation, Antitrust, Foreign Investment, Incentives, Data Privacy, Blockchain, Cyber, AI and more. We have a complete view of the issues facing both investors and growth companies, enabling us to solve those issues in the right way for the particular client rather than rely on “market practice”.

Key Experience

SoftBank Vision Fund as the lead investor in Revolut series E fundraising

We advised SoftBank Vision Fund as the lead investor in Revolut’s USD800 million series E fundraising round, valuing Revolut at approximately USD33 billion, making it the most valuable fintech company in the UK at the time.

Monzo on its 2024 series I fundraising

We have advised Monzo since it was founded in 2015. We most recently supported its Series I fundraising, which was led by CapitalG, Alphabet’s independent growth fund, and valued Monzo at c. £4 billion.

Oxford Nanopore from start-up to IPO

We advised Oxford Nanopore Technologies plc from start-up through to its initial public offering on the Main Market of the London Stock Exchange, described by Bloomberg as “one of London’s best-ever debuts”.

PrimaryBid from start-up to its latest Series C fundraising

We advised retail investment platform PrimaryBid Limited from start-up through to its latest USD190 million Series C fundraising, led by SoftBank Vision Fund 2.

Oxford Science Enterprises on a £250 million capital raise

We advised Oxford Science Enterprises on its £250 million capital raise. OSE is an independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford.

Immunocore on its Series B fundraising

We advised Immunocore, a clinical-stage T cell receptor biotechnology company, on its USD130 million Series B fundraising.

SideQuest on its Series A funding round

We advised SideQuest, a community platform that enables discovery of VR content for devices such as Meta Quest 2, on its USD12 million Series A funding round, led by Google Ventures.

Aviva Ventures on £500 million Series A equity investment in Neos

We advised Aviva Ventures, as lead investor alongside Munich Re, on a £500 million Series A equity investment in Neos, a company which combines smart home technology with home insurance in the UK.